Summary
Information concerning the expression kinetics and subcellular localization of HIV regulatory proteins is of importance in understanding the viral pathogenesis and may be relevant for drug and vaccine development, as well. We have used combined immunocytochemistry and in situ hybridization to study firstly, the order of expression of regulatory HIV-1 proteins Nef, Rev and Tat in relation to non-spliced and spliced mRNA expression and secondly, the subcellular localization of these proteins in acutely and chronically infected human T-cell lines. We used monoclonal antibodies against HIV-1 Nef, Tat, Rev and gp160, and RNA probes reacting either with all mRNAs (nef) or only with the full-length mRNA (gag-pol). In acutely infected MT-4 and H9 cells, four distinct phases of infection could be defined. In the first phase lasting from 0 to 6 h post-infection, only incoming virus could be demonstrated by gp160 immunocytochemistry. During the second, regulatory phase (6–9 h), abundant cytoplasmic expression of Nef, Rev and Tat proteins and a positive in situ RNA hybridization with the nef probe was seen, while the in situ hybridization with full-length mRNA probe and immunohistochemistry for gp160 were still negative. The productive phase (12–48 h) was characterized by abundant expression of full-length mRNA and gp160, and by the nuclear localization of Nef and Tat proteins. In contrast, an antibody that recognized the RRE binding region of the Rev protein localized Rev in the cytoplasm both during the regulatory and productive phase. During the fourth, cytopathic phase, the expression of mRNA or viral proteins decreased and the regulatory proteins studied were again mainly localized in the cytoplasm. Based on the results, we speculate that HIV Nef may function as a nuclear factor, and that Tat is possibly bound by cellular proteins before its transport to the nucleus.
Article PDF
Similar content being viewed by others
References
Acland PM, Dixon G, Peters G, Dickson C (1990) Subcellular fate of the Int-2 oncoprotein is determined by choice of initiation codon. Nature 343: 662–664
Ahmad N, Venkatesan S (1988) Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241: 1481–1485
Arya S, Guo C, Josephs S, Wong-Staal F (1985) Trans-activator gene of human T-lymphotropic virus type III. Science 229: 69–73
Brady H, Pennington D, Miles C, Dzierzak E (1993) CD4 cell surface downregulation in HIV-11 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J 12 4923–4932
Bugler B, Bourbon H, Lapeyre B, Wallace MO, Chang JH, Amalric F, Olson MO (1987) RNA binding fragments from nucleolin contain the ribonucleoprotein consensus sequence. J Biol Chem 262: 10922–10925
Bukrinsky M, Sharova N, Dempsey M, Stanwick T, Bukrinskaya AG, Haggertis S, Stevenson M (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complex. Proc Natl Acad Sci USA 89: 6580–6584
Cheng-Mayer C, Iannello P, Shaw K, Luciw P, Levy JA (1989) Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science 246: 1629–1632
Cullen BR (1992) Mechanism of action of regulatory protein encoded by complex retroviruses. Microbiol Rev 56: 375–394
D'Agostino DM, Felber BK, Harrison JE, Pavlakis GN (1992) The rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol Cell Biol 12: 1375–1386
DeRonde A, Klaver B, Keulen WL, Smit L, Goudsmit J (1992) Natural HIV-1 nef accelerates virus replication in primary human lymphocytes. Virology 188: 391–395
Felber B, Hadzopulou-Cladaras M, Cladaras C, Copeland T, Pavlakis G (1989) Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci USA 86: 1495–1499
Fisher A, Ratner L, Mitsuya H, Marselle LM, Harper M, Broder S, Gallo RC, Wong-Staal F (1986) Infectious mutants of HTLV-III with changes in the 3′ region and markedly reduced cytopathic effects. Science 233: 655–659
Franchini G, Robert-Guroff M, Wong-Staal F, Ghraeyb J, Kato I, Chang T (1986) Expression of the 3'orf of HTLV-III in bacteria: demonstration of its immunoreactivity with human sera. Proc Natl Acad Sci USA 83: 5282–5289
Garcia JV, Miller ASD (1991) Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350: 508–509
Gatignol A, Kumar A, Rabson A, Jeang K-T (1989) Identification of cellular proteins that bind to the human immunodeficiency virus type 1 transactivation-responsive TAR element RNA. Proc Natl Acad Sci USA 86: 7828–7832
Greenway A, McPhee D, Grgacic E, Hewish D, Lucantoni A, MacReadie I, Azad A (1994) Nef 27, but not Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology 198: 245–256
Guy B, Kieny MP, Riviere Y, Le Peuch C, Dott K, Girard M, Montagnier L, LeCocq J (1987) HIVF/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330: 266–269
Guy B, Acres B, Kieny M-P, Lecocq J-P (1990) DNA binding factors that bind to the negative regulatory element of the human immunodeficiency virus 1: regulation by NEF. J AIDS 3: 797–809
Guy B, Riviere Y, Doh K, Regnault A, Kieny M-P (1990) Mutational analysis of the HIV nef protein. Virology 176: 413
Harada S, Koyanagi Y, Yamamoto N (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563–566
Harper M, Marselle LM, Gallo RC, Wong-Staal F (1986) Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci USA 83: 772–776
Hauber J, Perkins A, Heimer EP, Cullen BR (1987) Trans-activation of human immunodeficiency virus gene expression in mediated by nuclear events. Proc Natl Acad Sci USA 84: 6364–6368
Herrman C, Rive AS (1993) Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197: 601–608
Inonue M, Koga Y, Djordjijevic D, Fukuma T, Reddy EP, Yokoyama MM, Sagawa K (1993) Down-regulation of CD4 molecules by the expression of Nef: a quantitative analysis of CD4 antigens on the cell surfaces. Int Immunol 5: 1067–1073
Kamine J, Subramanian T, Chinnadurai G (1991) Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 88: 8510–8514
Kienzle N, Bachman M, Müller W, Müller-Lantzch N (1992) Expression and cellular localization of the Nef protein from human immunodeficiency virus-I in steady transfected B-cells. Arch Virol 124: 123–132
Kim S, Byrn R, Groopman J, Baltimore D (1989) Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol 63: 3708–3713
Kim S, Ikeuchi K, Byr R, Groopman J, Baltimore D (1989) Lack of negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 86: 9544–9548
Kestler HW III, Ringler D, Mori K, Panicali D, Sehgal P, Daniel M, Desrosiers RC (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651–662
Kohleisen B, Neumann M, Herrmann R, Brack-Werner R, Krohn KJE, Ovod V, Ranki A, Erfle V (1992) Cellular localization of Nef expressed in persistently HIV-1 infected low-producer astrocytes. AIDS 6: 1427–1436
Krohn K, Robey WG, Putney S, Arthur L, Fishinger P, Gallo RC, Wong-Staal F, Ranki A (1987) Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type HTLV-IIIB and in human immunodeficiency virus-infected men. Proc Natl Acad Sci USA 84: 4994–4998
Krohn K, Ovod V, Lagerstedt A, Saarialho-Kere U, Ranki A, Gombert FO, Jung G (1991) Expression kinetics and cellular localization of HIV Tat and Nef proteins in relation to the expression of viral structural mRNA and viral particles. Vaccines-91. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 97–101
Luciw P, Cheng-Mayer C, Levy J (1987) Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc Natl Acad Sci USA 84: 1434–1438
Malim MH, Hauber J, Le SV, Maize V, Cullen BR (1989) The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338: 254–257
Miyazaki Y, Takamatsu T, Nosaka T, Fujita S, Hatanaka M (1992) Intranuclear topological distribution of HIV-1 trans-activators. FEBS Lett 305: 1–5
Mori S, Takada R, Shimotohno K, Okamoto T (1990) Repressive effect of the nef cDNA of human immunodeficiency virus type 1 on the promoter activity of the viral long terminal repeat. Jpn J Cancer Res 81: 1124–1131
Munis J, Kornbluth R, Guatelli J, Richman P (1992) Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages. J Gen Virol 73: 1899–1906
Murti KG, Brown PS, Ratner L, Garcia JV (1993) Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4+ T-cell line. Proc Natl Acad Sci USA 90: 11895–11899
Myers G, Robson A, Berzofsky J, Smith T, Wong-Staal F (1990) Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos
Nelbock P, Dillon PJ, Perkins A, Rosen C (1990) A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248: 1650–1653
Niederman T, Thielan B, Ratner L (1989) Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc Natl Acad Sci USA 86: 1128–1132
Niederman TM, Garcia JV, Hastings WR, Luria S, Ratner L (1992) Human immunodeficiency virus type 1 nef protein inhibits NV-κB induction in human T cells. J Virol 66: 6213–6219
Ovod V, Lagerstedt A, Ranki A, Gombert FO, Spohn R, Tähtinen M, Krohn KJE (1992) Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS 6: 25–34
Paul J (ed) Cell and tissue culture, 5th edn. Churchill, Livingstone
Pomerantz RJ, Trono D, Feinberg M, Baltimore D (1990) Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61: 1271–1276
Ranki A, Kianto U, Kanerva L, Tolvanen E, Johansson E (1984) Immunohistochemical and microscopical characterization of the cellular infiltrate in alopecia (areata, totalis and universalis.) J Invest Dermatol 83: 7–11
Ruben S, Perkins A, Purcell R, Joung K, Sia R, Burghoff R, Haseltine W, Rosen C (1989) Structural and functional characterization of human immunodeficiency virus TAT protein. J Virol 63: 1–8
Samuel K, Hodge DR, Chen Y, Papas S (1991) NEF proteins of the human immunodeficiency virus (HIV-1 and HIV-2) and simian immunodeficiency virus (SIV) are structurally similar to leucine zipper transcriptional activation factors. AIDS Res Hum Retroviruses 7: 697–706
Sheline CT, Milocco LH, Jones KA (1991) Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev 5: 2508–2520
Shibuya H, Irie K, Ninomiya-Tsuji J, Goebl M, Taniguchi T, Matsumato K (1992) New human gene encoding a positive modulator of HIV Tat-mediated transactivation. Nature 357: 700–701
Steffy K, Wong-Staal F (1991) Genetic regulation of human immunodeficiency virus. Microbiol Rev 55: 193–205
Terwilliger E, Sodrowski J, Rosen C, Haseltine WA (1986) Effects of mutations with the 3'orf open reading frame region of human T-lymphotropic virus type III (HTLV-III/&LAV) on replication and cytopathogenicity. J Virol 60: 754–760
Tähtinen M, Gombert FO, Hyytinen E-R, Jung G, Ranki A, Krohn K (1992) Fine specificity of the B cell epitopes recognized in HIV-1 NEF by human sera. Virology 187: 156–164
Yu G, Felsted RL (1992) Effect of myristoylation of p 27 Nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187: 46–55
Zazopoulos E, Haseltine WA (1992) Mutational analysis of the human immunodeficiency virus type 1 ELI Nef function. Proc Natl Acad Sci USA 89: 6634–6638
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ranki, A., Lagerstedt, A., Ovod, V. et al. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Archives of Virology 139, 365–378 (1994). https://doi.org/10.1007/BF01310798
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01310798